COMMUNIQUÉS West-GlobeNewswire

CEO of TRHC’s New Research & Development Institute to Present at National University of Singapore
25/02/2019
MOORESTOWN, N.J., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced that TRHC’s Chief [...]
Inovalon to Present at Morgan Stanley Technology, Media & Telecom Conference
25/02/2019
BOWIE, Md., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading technology company providing advanced, cloud-based platforms empowering data-driven healthcare, today announced that Keith Dunleavy, M.D [...]
Ziopharm Oncology to Announce Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on March 5
25/02/2019
BOSTON, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq:ZIOP) today announced that management will host a conference call and webcast slide presentation on Tuesday, March 5, at 4:30 p.m. ET to provide [...]
Blueberries Medical Enters into Agreement with a Leading Colombian Craft Brewer to Pioneer the Development and Commercialization of Cannabis Based Beverages in Latin America
25/02/2019
TORONTO, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (the “ Company ” or " Blueberries ") a leading Colombia-based licensed producer of medicinal cannabis and cannabis-derived products, [...]
ADMA Biologics to Present at Upcoming Investor Conferences
25/02/2019
Raymond James 40 th Annual Institutional Investors Conference Oppenheimer’s 29 th Annual Healthcare Conference RAMSEY, N.J. and BOCA RATON, Fla., Feb. 25, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ [...]
REVA Announces Extension to Voluntary Suspension of Trading
25/02/2019
SAN DIEGO, Feb. 24, 2019 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”) said today that on 25 February 2019 (AEDT), the Australian Securities Exchange issued a market announcement indicating [...]
Philips showcases unique augmented reality concept for image-guided minimally invasive therapies developed with Microsoft
24/02/2019
February 24, 2019 Companies collaborate to combine Philips’ industry-leading Azurion image-guided therapy platform with Microsoft HoloLens 2 mixed reality computing platform as a concept for the operating room of the [...]
BioCryst Reports ZENITH-1 Results With Oral BCX7353 Which Confirm Rapid Onset of Action, Sustained Activity and Robust Dose Response for Treatment of Acute HAE Attacks
23/02/2019
— Based on ZENITH-1 data, company plans to commence Phase 3 trial of single-dose 750 mg oral BCX7353 for acute treatment of hereditary angioedema (HAE) attacks in summer 2019— —Data show excellent clinical dose response [...]
FibroGen Reports Fourth Quarter and Full Year 2018 Financial Results
23/02/2019
SAN FRANCISCO, Feb. 22, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN), a leading biopharmaceutical company discovering and developing a pipeline of first-in-class therapeutics, today announced that it will [...]
SHDS Informs Individuals of Security Incident Affecting Subset of Patients of East Los Angeles Doctors Hospital and Other Customers
23/02/2019
SAN DIEGO, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Sharecare Health Data Services (“SHDS”), formerly known as BACTES Imaging Solutions, announced today that some personal information, including protected health information, [...]
Fluidigm to Participate in Upcoming Investor Conferences
22/02/2019
SOUTH SAN FRANCISCO, Calif., Feb. 22, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced [...]
Alder BioPharmaceuticals® Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
22/02/2019
BOTHELL, Wash., Feb. 22, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (Nasdaq: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
OrthoPediatrics Corp. Honored as One of the Best Place to Work in Indiana for a Third Year
22/02/2019
WARSAW, Ind., Feb. 22, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce that it was recently named as [...]
priMED Medical Products Named 2019 Alberta’s Top Employer
22/02/2019
Corporate culture, working environment, employee health, and social responsibility cited as key factors in winning the award EDMONTON, Alberta, Feb. 22, 2019 (GLOBE NEWSWIRE) -- After a banner year in 2018, priMED [...]
Canaccord Genuity initiates research coverage of CLS Holdings
22/02/2019
LAS VEGAS, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Canaccord Genuity, the largest independent investment dealer in Canada, has initiated research coverage of CLS Holdings USA Inc. (OTCQB:CLSH). The initiation report is 38 [...]
Constellation Pharmaceuticals to Present at Upcoming Investor Conferences
22/02/2019
CAMBRIDGE, Mass., Feb. 22, 2019 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel [...]
Notice Convening the Annual General Meeting
22/02/2019
February 22, 2019 Announcement no. 3 NOTICE CONVENING THE ANNUAL GENERAL MEETING The Board of Directors hereby convenes the Annual General Meeting of BioPorto A / S (the “Company”): March 18, 2019, at 3.00 pm (CET), At [...]
Aura Health Provides Further Clarity Regarding Offering and Strategic Investor
22/02/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. TORONTO, Feb. 22, 2019 ( [...]
DBV Technologies Announces Publication of Detailed Phase III Trial Results Evaluating Viaskin Peanut as a Novel Treatment for Peanut Allergy in The Journal of the American Medical Association
22/02/2019
Montrouge, France, February 22, 2019 DBV Technologies Announces Publication of Detailed Phase III Trial Results Evaluating Viaskin Peanut as a Novel Treatment for Peanut Allergy in The Journal of the American Medical [...]

Pages